Malignant pleural effusion

Updated: July 12, 2022

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

bleomycin

units

Intravenous (IV)

as a single installation, mix in 50 to 100ml normal saline.

talc

It is indicated to reduce pleural effusion malignancy that re-occurs in symptomatic patients
Intrapleural administration through the chest tube after effusion drainage
Aerosol- 4-8 gm in 1-2 canisters can be delivered manually by pressing the actuator
Short bursts help in distributing the talc evenly on the parietal and visceral pleural surfaces
Powder- 5 gm single dose is diffused in sodium chloride injection of 50-100 ml
The dose ranges from 2-10.5 gm, as effectively shown